Open AccessGenotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low‐dose Cytarabine: “Real World” Data From Germany
Author(s) -
Braitsch Krischan,
Schmalbrock Laura K.,
Jung Paul,
Bumeder Irmgard,
Kiewe Philipp,
Hecker Judith S.,
Verbeek Mareike,
Westermann Jörg,
Bullinger Lars,
Keller Ulrich,
Bassermann Florian,
Krönke Jan,
Götze Katharina S.,
Rieger Kathrin
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000759
Subject(s) - medicine , venetoclax , ven , cytarabine , myeloid leukemia , oncology , leukemia , chronic lymphocytic leukemia , computer security , computer science